Conclusion: All antidepressants were more efficacious than placebo in adults with major depressive disorder. Smaller differences between active drugs were found when placebo-controlled trials were included in the analysis, whereas there was more variability in efficacy and acceptability in head-to-head trials. These results should serve evidence-based practice and inform patients, physicians, guideline developers, and policy makers on the relative merits of the different antidepressants.
PubMed 29477251 ↗Trazodone
Also known as Desyrel
The short answer. People are split on Trazodone — 51% of 59 say it helped. It is most often used for sleep: 84% of 56 reports say that improved. It is well studied — 105 meta-analyses on PubMed. The most common complaint is drowsiness.
From 93 mentions in total — the rest didn't say how it went and aren't counted.
What Trazodone does, according to users
Of the people who reported each effect, the share who said it got better.
4 more with fewer than 3 reports
What the research says
Systematic reviews and meta-analyses from PubMed, with their published conclusions.
3+ meta-analyses or systematic reviews and 10+ randomized controlled trials in humans. The grade measures how much human research exists — read the conclusions below for what it found. 105 meta-analyses on PubMed ↗ · 165 randomized trials ↗
Conclusion: In this systematic review and network meta-analysis, mirtazapine, biperiden, and vitamin B6 were associated with the greatest efficacy for AIA, with vitamin B6 having the best efficacy and tolerance profile. Trazodone, mianserin, and propranolol appeared as effective alternatives with slightly less favorable efficacy and tolerance profiles. These findings should assist prescribers in selecting an appropriate medication for treating AIA.
PubMed 38451521 ↗Conclusion: Overall, eszopiclone and lemborexant had a favorable profile, but eszopiclone might cause substantial adverse events and safety data on lemborexant were inconclusive. Doxepin, seltorexant, and zaleplon were well tolerated, but data on efficacy and other important outcomes were scarce and do not allow firm conclusions. Many licensed drugs (including benzodiazepines, daridorexant, suvorexant, and trazodone) can be effective in the acute treatment of insomnia but are associated with poor tolerability, or information about long-term effects is not available. Melatonin, ramelteon, and non-licensed
PubMed 35843245 ↗Conclusion: Trazodone extends total sleep time but does not affect perceived sleep duration. It may improve sleep quality and continuity but has minor effects on sleep latency, efficiency, and daytime impairment. Trazodone is associated with adverse effects, necessitating a careful risk-benefit assessment. Limited data restrict generalizability, underscoring the need for more research.
PubMed 39123094 ↗84 human trials on ClinicalTrials.gov test Trazodone — 44 completed, 19 recruiting now. See all on ClinicalTrials.gov ↗
- Parallel Arm Trial of AD109 and AD504 In Patients With OSA · OSA - Obstructive Sleep Apnea · 2022
- National Adaptive Trial for PTSD Related Insomnia · Insomnia · 2026
- Pharmacological Treatment Targeting Endotypic Traits of Obstructive Sleep Apnea · Obstructive Sleep Apnea of Adult · 2025
What government agencies say
Official records from US, Canadian and EU regulators, each linked to its source.
Boxed warning (the FDA's strongest label warning): “SUICIDAL THOUGHTS AND BEHAVIORS Antidepressants increased the risk of suicidal thoughts and behaviors in pediatric and young adult patients in short-term studies. Closely monitor all antidepressant-treated patients for clinical worsening, and for emergence of suicidal thoughts and behaviors.…”
9 recalls of products named for Trazodone. Most recent:
- 2026-09-09 · Class II: Presence of Foreign Tablets/Capsules record ↗
- 2026-02-11 · Class II: Presence of Foreign Tablets/Capsules record ↗
- 2026-01-07 · Class III: Failed Tablet/Capsule Specifications: Product complaint received that some tablets had a dent on the plain side of the tablet surface. record ↗
Class I = could cause serious harm; Class II = temporary or reversible harm; Class III = unlikely to cause harm. Recalls are of specific products and lots, not of the ingredient itself. All recalls (openFDA) ↗
15,550 adverse-event reports mention Trazodone. Most often reported:
- Drug ineffective · 1,212
- Fatigue · 1,157
- Nausea · 1,123
- Headache · 924
- Pain · 823
- Diarrhoea · 817
Reports often involve several drugs and serious illness; a report doesn't prove the drug caused the problem, and these counts can't tell you how often it happens. Source query (openFDA) ↗
LiverTox rates Trazodone B — a highly likely cause of liver injury (12–50 published cases). LiverTox entry ↗
NIH has funded 12 research projects with Trazodone in the title, $17,931,572 in total (1992–2026). NIH RePORTER ↗
Plain-language guides from the US government: MedlinePlus: Trazodone ↗
Dosage people report
Reported side effects
How often each side effect came up across all reports.
What users say
First-hand experiences, quoted verbatim. We show one positive and one negative where both exist.
“I take 1/3 of a serving/dose of Om Sleep and 50mg of trazodone and caps of Tart cherry. The traz gets me to sleep, and the Om keeps me asleep.”
“nothing really beats trazodone so far. Even half of one knocks me out.”
“One that I found particularly useful in this regard, that is also known for not causing dependence is trazodone - 50mg is popular off-label to induce sleep.”
“Well I've had good results with trazodone for sleep. It also doubles as an antidepressant.”
Other options for sleep
Sources
- User reports: 93 mentions in public discussions, quoted with a link to each discussion (e.g. this thread ↗).
- PubMed (US National Library of Medicine, NIH): meta-analyses ↗ · randomized trials ↗
- ClinicalTrials.gov (NIH): registered trials ↗
- FDA drug label (DailyMed) ↗
- FDA adverse-event reports (FAERS) ↗
- FDA recalls ↗
- LiverTox (NIH) ↗
- MedlinePlus (NIH) ↗
- NIH RePORTER ↗
User data from public discussions; research from PubMed. Information only, not medical advice — talk to a doctor before starting, stopping or combining anything. Data updated October 5, 2026. How we rate